title: Effects of exogenous vasoactive intestinal peptide on mesenteric lymph pathway during early intestinal ischemia-reperfusion injury in rats.
abstract: Mesenteric lymph pathway serves as the primary route by which gut injury leads to systemic inflammation and distant organ injury. The inflammation of the intestinal tract is partially mediated by vasoactive intestinal peptide (VIP). Therefore, the aim of this study was to test whether exogenous VIP affects mesenteric lymph pathway during early intestinal ischemia-reperfusion (IIR) injury. Rats were randomized into control, control+VIP, IIR and IIR+VIP groups. The observation of mesenteric lymph flow was carried out by cannulation of mesenteric lymphatics. The distribution of in vivo lymphocyte trafficking was performed by (51)Cr labeled lymphocytes and was measured by γ-counter. Endotoxin concentration was assayed using the limulus test kit and TNF-α level was detected by ELISA. When IIR injury treated with VIP, the volumes of lymph flow increased by 80%, which caused the number of lymphocytes exiting in mesenteric lymphatic increased by 50% while the proportion of (51)Cr-lymphocytes in Peyer's patches, intestinal effector tissues, mesenteric nodes, large intestine, stomach decreased by 58%, 51%, 58%, 63%, 64% respectively at the 6th h after reperfusion following intestinal ischemia. Meanwhile, endotoxin and TNF-α levels in intestinal lymph decreased by 51% and 83%. These results suggest that exogenous VIP ameliorates IIR induced splanchnic organ damage via inhibition of toxic mediators reaching systemic circulation and reinforcement of the effective immune responses in gut-associated lymphoid tissues (GALT).
authors.affiliation: Department of Gastroentrology, Nanjing Children's Hospital, Nanjing Medical University, 210008, China.
authors.forename: Hui
authors.initials: H
authors.lastname: Yang
authors.forename: Yu
authors.initials: Y
authors.lastname: Jin
authors.forename: Chun H
authors.initials: CH
authors.lastname: Wang
authors.forename: Cheng W
authors.initials: CW
authors.lastname: Tang
mesh_terms: D000818:Animals; D002465:Cell Movement; D004353:Drug Evaluation, Preclinical; D004731:Endotoxins / Q000097:blood; D007082:Ileum / Q000098:blood supply / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D008196:Lymph / Q000276:immunology; D042601:Lymphatic Vessels / Q000503:physiopathology; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000276:immunology / Q000502:physiology; D008297:Male; D008638:Mesenteric Arteries / Q000503:physiopathology; D008641:Mesenteric Vascular Occlusion / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology* / Q000502:physiology
chemical_list: D004731:Endotoxins; D014409:Tumor Necrosis Factor-alpha; D014660:Vasoactive Intestinal Peptide
keywords: Intestinal injury; Ischemia–reperfusion; Lymph flow; Lymphocyte trafficking; VIP